Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Comment by TheMonolithon Aug 08, 2018 10:28am
89 Views
Post# 28426717

RE:RE:Well..this is good news

RE:RE:Well..this is good newsI'm not sure if I believe you, but I want to.  You did prove truthful with your dip purchases a couple months back.  Everything you stated makes sense.  Insiders are going to guard their value.  

I was thinking they might consider moving to the US.  Don't know what that all entails.  The acquisition they've discussed they are pursuing is probably a US based company.  I wonder if that might come into play as far as a move.  They've qualified for the up-list for a while, yet we haven't seen movement in that direction.  Brian had said 6-8 months ago that 2018 would be a year they engage investors more and start to highly consider up-listing in CA and US.  

Covalon has needed to diversify out of Saudi and have only slowly done that so far.  This recent setback is going to accelerate the need, but also damage Covalon in the eyes of new investors for likely several months.  I don't think it changes the 18+ month projections for the stock, as long as Saudi contracts are intact and progres is made outside of it.  

Has to be one of the most random events to affect an individual company.  Sucks, but all should be fine longer term for those patient.  
Bullboard Posts